The spread of carbapenem-resistant Enterobacteriaceae in South Africa: Risk factors for acquisition and prevention

被引:35
作者
Brink, Adrian [1 ]
Coetzee, Jennifer [2 ]
Clay, Cornelis [2 ]
Corcoran, Craig [2 ]
van Greune, Johan [4 ]
Deetlefs, J. D. [4 ]
Nutt, Louise [3 ]
Feldman, Charles [5 ,6 ,7 ]
Richards, Guy [5 ,6 ,7 ]
Nordmann, Patrice [8 ,9 ]
Poirel, Laurent [8 ,9 ]
机构
[1] Milpk Hosp, Dept Clin Microbiol, Ampath Natl Lab Serv, Johannesburg, South Africa
[2] Natl Reference Lab, Dept Clin Microbiol & Mol Biol, Ampath Natl Lab Serv, Centurion, Gauteng, South Africa
[3] Ampath Natl Lab Serv, Port Elizabeth, South Africa
[4] Ampath Natl Lab Serv, Cape Town, South Africa
[5] Charlotte Maxeke Johannesburg Acad Hosp, Dept Crit Care, Johannesburg, South Africa
[6] Charlotte Maxeke Johannesburg Acad Hosp, Div Pulrnonol, Johannesburg, South Africa
[7] Univ Witwatersrand, Johannesburg, South Africa
[8] Hosp Bicetre, Assistance Publ Hop Paris, Serv Bacteriol Virol, Fac Med, K Bicetre, France
[9] Univ Paris 11, K Bicetre, France
来源
SAMJ SOUTH AFRICAN MEDICAL JOURNAL | 2012年 / 102卷 / 07期
关键词
KLEBSIELLA-PNEUMONIAE; EMERGENCE; EPIDEMIOLOGY; COLISTIN; KPC-2;
D O I
10.7196/SAMJ.5789
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
New, effective antibiotics are only likely to become available in 15 - 20 years. To prevent deaths from untreatable Gram-negative infections in South Africa, the rights of any doctor, whether in general or in hospital practice, to indiscriminately prescribe whatever antibiotic they wish, and in whatever fashion, must be challenged. Furthermore, although prevention of the emergence and subsequent spread of carbapenem-resistant Enterobacteriaceae (CRE) has focused on acute and chronic care facilities and inter alia on antibiotic exposure in these institutions, CRE may soon become an issue within entire communities, highlighting a role for public health authorities in CRE prevention efforts.
引用
收藏
页码:599 / 601
页数:3
相关论文
共 14 条
  • [1] Bamford C., 2011, Southern African Journal of Epidemiology & Infection, V26, P243
  • [2] Brink A, 2008, SAMJ S AFR MED J, V98, P586
  • [3] Antimicrobial Susceptibility of Gram-Negative Pathogens Isolated from Patients with Complicated Intra-Abdominal Infections in South African Hospitals (SMART Study 2004-2009): Impact of the New Carbapenem Breakpoints
    Brink, Adrian J.
    Botha, Roelof F.
    Poswa, Xoliswa
    Senekal, Marthinus
    Badal, Robert E.
    Grolman, David C.
    Richards, Guy A.
    Feldman, Charles
    Boffard, Kenneth D.
    Veller, Martin
    Joubert, Ivan
    Pretorius, Jan
    [J]. SURGICAL INFECTIONS, 2012, 13 (01) : 43 - 49
  • [4] Emergence of New Delhi Metallo-Beta-Lactamase (NDM-1) and Klebsiella pneumoniae Carbapenemase (KPC-2) in South Africa
    Brink, Adrian J.
    Coetzee, Jennifer
    Clay, Cornelis G.
    Sithole, Sindi
    Richards, Guy A.
    Poirel, Laurent
    Nordmann, Patrice
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (02) : 525 - 527
  • [5] Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
    Gupta, Neil
    Limbago, Brandi M.
    Patel, Jean B.
    Kallen, Alexander J.
    [J]. CLINICAL INFECTIOUS DISEASES, 2011, 53 (01) : 60 - 67
  • [6] Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection
    Hirsch, Elizabeth B.
    Tam, Vincent H.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (06) : 1119 - 1125
  • [7] Steady-State Pharmacokinetics and BAL Concentration of Colistin in Critically Ill Patients After IV Colistin Methanesulfonate Administration
    Imberti, Roberto
    Cusato, Maria
    Villani, Paola
    Carnevale, Livio
    Iotti, Giorgio A.
    Langer, Martin
    Regazzi, Mario
    [J]. CHEST, 2010, 138 (06) : 1333 - 1339
  • [8] Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 β-lactamase resistant to colistin
    Kontopoulou, K.
    Protonotariou, E.
    Vasilakos, K.
    Kriti, M.
    Koteli, A.
    Antoniadou, E.
    Sofianou, D.
    [J]. JOURNAL OF HOSPITAL INFECTION, 2010, 76 (01) : 70 - 73
  • [9] Antibiotic use and the risk of carbapenem-resistant extended-spectrum-β-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study
    Kritsotakis, Evangelos I.
    Tsioutis, Constantinos
    Roumbelaki, Maria
    Christidou, Athanasia
    Gikas, Achilleas
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (06) : 1383 - 1391
  • [10] Global Spread of Carbapenemase-producing Enterobacteriaceae
    Nordmann, Patrice
    Naas, Thierry
    Poirel, Laurent
    [J]. EMERGING INFECTIOUS DISEASES, 2011, 17 (10) : 1791 - 1798